| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/13/2000 | CN1059442C Use of 1,2-bridged 1,4-dihydropyridines as medicaments |
| 12/13/2000 | CN1059441C Benzopyranols, their preparing method, and their pharmaceutical composition and use |
| 12/13/2000 | CN1059438C Stable crystallized cis-isomer of methoxyimino-acetylchloride hydrochloride and process for preparing same |
| 12/13/2000 | CN1059436C Benzoazepine-benzooxaazepine-benzothiaazepin-N-acetate deriv. |
| 12/13/2000 | CN1059433C Arylalkyl (thio) carboxamides, processes forpreparing them and pharmaceutial composition contg. them |
| 12/13/2000 | CN1059324C Bones and tendon recovery cream |
| 12/13/2000 | CN1059322C Method for processing polypropylene for high molecular synthetic material double-fold eyelid operation |
| 12/13/2000 | CN1059321C Iron-cobalt-selenium-copper-arsenic injection |
| 12/13/2000 | CN1059319C Cosmetic and/or dematological composition with hydrophilic carrier and vitamine C which can be mixed before use |
| 12/12/2000 | US6160184 A chemical intermediate for forming a drug treating cancer |
| 12/12/2000 | US6160176 Anticoagulant agents |
| 12/12/2000 | US6160175 Naphthyl acetamides as sPLA2 inhibitors |
| 12/12/2000 | US6160141 Reacting a hydrocarbylsulfonic ester of methyl lesquerolate with diazabicycloundecene to form high yield of 11-cis, 13-trans eicosadienoic acid |
| 12/12/2000 | US6160135 Taxoids, preparation thereof and pharmaceutical compositions containing same |
| 12/12/2000 | US6160133 Stereospecific biosynthesis of the alcohol by enzymatic reduction of the corresponding aldehyde or ketone using a candida, zygosaccaromyces, or mortierrela microorganism |
| 12/12/2000 | US6160129 Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| 12/12/2000 | US6160124 Oxazole malonated intermediates for compounds that have superior hypoglycemic and hypolipidemic actions and are useful for the treatment of diabetes and the complications thereof, as well as therapeutic agents for related diseases such as |
| 12/12/2000 | US6160123 One pot synthesis of 2-oxazolidinone derivatives |
| 12/12/2000 | US6160120 Optically pure 7-chloro-2-(2-(3-(1-(7-(1h-tetrazol-5-ylmethoxy) indol-1-yl)-4-(1h-tetrazol-5-yl) butyl)phenyl)ethenyl)quinoline |
| 12/12/2000 | US6160119 Fused dihydropyrans |
| 12/12/2000 | US6160108 Platelet activation protein |
| 12/12/2000 | US6160106 Nucleotide sequences which code polypeptides which prevent gene expression; for use as diagnostic screening tools in the detection and treatment of cancer; anticarcinogenic agents |
| 12/12/2000 | US6160098 Preparing a fixed erythrocyte transport protein having preferential physical properties; obtain deoxygenated erythrocyte transport protein and controlling physical properties of solution during fixation |
| 12/12/2000 | US6160094 Enzymatic polypeptide; for use as a wound healing agent; for use in dentistry to prevent of adhesion of bacteria in wounds |
| 12/12/2000 | US6160087 Peptides having an amino acid sequence from the fimbrial protein of porphyromonas gingivalis and their uses |
| 12/12/2000 | US6160024 Photoactivated antiviral and antitumor compositions |
| 12/12/2000 | US6160023 Treatment of an aquatic organism suffering from a disease selected from the group consisting of fungal infections, flagellate protozoan infections, ciliate protozoan infections, bacterial gill disease, and myxobacterial infections |
| 12/12/2000 | US6160022 Chemical resection of pancreas |
| 12/12/2000 | US6160021 Administering to the subject a treatment which modulates the level of nitric oxide in the skin |
| 12/12/2000 | US6160020 Alkali metal and alkaline-earth metal salts of acetaminophen |
| 12/12/2000 | US6160019 Dissolving 0.1 to 10% w/v of nimesulide in 2 to 90% w/v of dimethylacetamide to form a solution, adding benzyl alcohol, polyethylene glycol, hydrochloric acid, propylene glycol |
| 12/12/2000 | US6160018 Administering to a patient in need of such treatment a composition having an effective alzheimer's disease prophylactic amount of an enantiomerically stable r-nsaid or a pharmaceutically acceptable salt thereof |
| 12/12/2000 | US6160017 Preventives and remedies for ulcerous colitis and/or crohn's disease |
| 12/12/2000 | US6160016 Calcium formate composition for oral administration to an individual for the purpose of inhibiting gastrointestinal absorption of phosphorous |
| 12/12/2000 | US6160015 Administering to mammal a farnesyl protein transferase inhibitor |
| 12/12/2000 | US6160012 Leukotriene B4 derivatives, in particular oximo-LTB4 - antagonists |
| 12/12/2000 | US6160011 Non-steroidal agonist compounds and their use in male hormone therapy |
| 12/12/2000 | US6160010 For increasing sensitivity of cancer cells to chemotherapy |
| 12/12/2000 | US6160009 Excitatory amino acid receptor modulators |
| 12/12/2000 | US6160008 Pharmaceutical compositions comprising S-alkylisothiouronium derivatives |
| 12/12/2000 | US6160007 Method for enhancing the absorption and transport of lipid soluble compounds using structured glycerides |
| 12/12/2000 | US6160006 Inhibits the activity of the cytochrome p450 3a sub-family of enzymes, specifically, cyp3a4 |
| 12/12/2000 | US6160005 Administering alkylenedioxybenzene derivative |
| 12/12/2000 | US6160004 C-10 carbon-substituted artemisinin-like trioxane compounds having antimalarial, antiproliferative and antitumor activities |
| 12/12/2000 | US6160003 Antitumor and anticarcinogenic agents |
| 12/12/2000 | US6160002 1-arylpyrazole derivatives; pesticides, parasiticides; veterinary medicine |
| 12/12/2000 | US6160000 Antidiabetic agents based on aryl and heteroarylacetic acids |
| 12/12/2000 | US6159998 Administered as vasodilators, analgesics, anesthetics, sedatives, and anitspasmodic agents |
| 12/12/2000 | US6159997 Treatment of arteriosclerosis and xanthoma |
| 12/12/2000 | US6159996 Polycyclic thiazolidin-2-ylidene amines, process for their preparation, and their use as pharmaceuticals |
| 12/12/2000 | US6159995 Substituted diaminocarboxylic acids |
| 12/12/2000 | US6159993 Methods and compositions for the rapid and enduring relief of inadequate myocardial function |
| 12/12/2000 | US6159990 Hypotensive agents for intraocular pressure; antiarrhythmia agents, benign prostate hyperplasia |
| 12/12/2000 | US6159987 Bicyclolactam compounds, use thereof and intermediates for preparing thereof |
| 12/12/2000 | US6159986 Compounds and therapy for resisting memory loss in humans |
| 12/12/2000 | US6159983 Method and composition for treatment of inflammatory bowel disease |
| 12/12/2000 | US6159982 Treating psychological disorders, schizophrenia |
| 12/12/2000 | US6159981 3-substituted pyrido [3',4':4,5] Thieno [2,3-d] pyrimidine derivatives, and production and use of the same |
| 12/12/2000 | US6159980 Anxiolytic agents, antidepressants; psychological and eating disorders |
| 12/12/2000 | US6159979 Bicyclic aryl or a bicyclic heterocyclic ring containing compounds having a combined 5HT1A, 5HT1B and 5HT1D receptor antagonistic activity |
| 12/12/2000 | US6159978 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases |
| 12/12/2000 | US6159977 Therapeutic anti-fungal nail preparation |
| 12/12/2000 | US6159974 LDL receptor gene expression promoters |
| 12/12/2000 | US6159973 Aromatic amides, their preparation process, the compositions containing them and their use as pesticides |
| 12/12/2000 | US6159972 Enzyme inhibitors |
| 12/12/2000 | US6159971 Combination of a 5-HT reuptake inhibitor and a h5-HT1B anatagonist or partial agonist |
| 12/12/2000 | US6159970 Enzyme inhibitors |
| 12/12/2000 | US6159968 Benzimidazole pyridine drugs |
| 12/12/2000 | US6159967 such as 1-(2-((2R)-(3,4-dichlorophenyl)-4-(3,4,5-trimethoxybenzoyl) morpholin-2-yl)ethyl)spiro(benzo(c)thiophene-1-(3H), 4'-piperidine)-(2S)-oxide; respiratory disease such as asthma |
| 12/12/2000 | US6159964 Vitronectin receptor antagonists |
| 12/12/2000 | US6159963 Method for treating substance abuse |
| 12/12/2000 | US6159962 3-substituted 3,4-dihydro-thieno[2,3-D]pyrimidine derivatives and production and use of the same |
| 12/12/2000 | US6159961 Cephem compounds |
| 12/12/2000 | US6159960 Steroid sulphatase inhibitors |
| 12/12/2000 | US6159959 Combined estrogen and antiestrogen therapy |
| 12/12/2000 | US6159958 Treatment or prophylaxis of retinal pathology and spinal cord injury |
| 12/12/2000 | US6159957 Antitumor agents |
| 12/12/2000 | US6159955 Use of hyaluronic acid and a NSAID for the manufacture of a medicament for the treatment of mucosal diseases |
| 12/12/2000 | US6159954 Keratan sulfate oligosaccharide fraction and pharmaceutical containing the same |
| 12/12/2000 | US6159953 Anti-malarial composition and method of use |
| 12/12/2000 | US6159952 Bronchodilator agents |
| 12/12/2000 | US6159949 Polynucleotides, codes and amino acid sequences |
| 12/12/2000 | US6159947 Isolation of nucleic acids and gene codes |
| 12/12/2000 | US6159946 Antisense inhibition of c-myc to modulate the proliferation of smooth muscle cells |
| 12/12/2000 | US6159944 Method for treating painful conditions of the anal region and compositions therefor |
| 12/12/2000 | US6159943 Use of ribose to prevent cramping and soreness in muscles |
| 12/12/2000 | US6159942 Administering a pentose to increase energy |
| 12/12/2000 | US6159941 Use of somatostatin agonists and antagonists for treating diseases related to the eye |
| 12/12/2000 | US6159932 Avermectin macrocyclic lactones and peptides |
| 12/12/2000 | US6159734 Nucleotide sequences which prevent or reduce transcription of human gene; for the treatment of non-insulin dependent diabetes, cardiovascular disorders and gastrointestinal disorders; antiinflammatory agents; anticarcinogenic agents |
| 12/12/2000 | US6159732 Nucleic acid encoding mammalian Ubr1 |
| 12/12/2000 | US6159716 Amino acid sequence of serine/threonine kinase; antiulcer/ anticarcinogenic/antiarthritic agents; treatment of parkinson's/huntigton's diseases, tourette's syndrome, eating disorders, osteoporosis, allergies; diagnosis of disease |
| 12/12/2000 | US6159706 Application of enzyme prodrugs as anti-infective agents |
| 12/12/2000 | US6159700 Method of finding agonist and antagonist to human and rat GPR14 |
| 12/12/2000 | US6159697 Antisense modulation of Smad7 expression |
| 12/12/2000 | US6159694 Antisense modulation of stat3 expression |
| 12/12/2000 | US6159501 Modified release multiple-units dosage composition for release of opioid compounds |
| 12/12/2000 | US6159500 Pharmaceutical preparations of glutathione and methods of administration thereof |
| 12/12/2000 | US6159499 Composition containing an acid-labile benzimidazole and process for its preparation |
| 12/12/2000 | US6159493 Comprising polyvinyl alcohol solution, polyvinyl pyrrolidone, and excipient |